Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.48 |
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.48 |
| ▸ | CA7 | P43166 | 3/20 | 0.48 |
| ▸ | CA9 | Q16790 | 3/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.48 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.44 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.44 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.43 |
| ▸ | NHERF1 | O14745 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | TDP2 | O95551 | 1/20 | 0.41 |
| ▸ | RARA | P10276 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14690993 | 0.83 | TDP2 (0.36) | CA1CA2CA7CA9PDK2 | |
| SCHEMBL21551956 | 0.81 | MAPT (0.39) | PDK2MAPTATMALDH1A1HPGD | |
| SCHEMBL21333830 | 0.79 | SRD5A2 (0.53) | PDK2CYP3A4RARARARBHPGD | |
| SCHEMBL4998169 | 0.79 | MAPT (0.47) | CA1CA2CA7CA9PDK2 | |
| SCHEMBL21551963 | 0.79 | HSD17B3 (0.42) | MAPTALDH1A1HPGDSTS | |
| SCHEMBL6536547 | 0.79 | SRD5A1 (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL14691381 | 0.78 | GSK3B (0.51) | PDK2ALDH1A1HPGD | |
| SCHEMBL22859290 | 0.78 | PDK2 (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL12154187 | 0.78 | RARA (0.52) | CA12CA1CA2CA7CA9 | |
| SCHEMBL22859291 | 0.77 | CA12 (0.42) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230194165-A1 | RADIOFREQUENCY HEATING OF WOOD USING A THREE-ELECTRODE SYSTEM HAVING A WINGED CENTRAL ELECTRODE | RF KILN TECH LIMITED (CA) | 2023-06-22 | — | — | US | disclosed |
| US-20230194165-A1 | RADIOFREQUENCY HEATING OF WOOD USING A THREE-ELECTRODE SYSTEM HAVING A WINGED CENTRAL ELECTRODE | RF KILN TECH LIMITED (CA) | 2023-06-22 | — | — | US | disclosed |
| US-11666637-B2 | Insulin-loaded metal-organic frameworks | NORTHWESTERN UNIVERSITY (US) | 2023-06-06 | — | — | US | disclosed |
| US-11666637-B2 | Insulin-loaded metal-organic frameworks | NORTHWESTERN UNIVERSITY (US) | 2023-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11666637-B2 | Insulin-loaded metal-organic frameworks | IAPP, IGFBP4, IGFBP1 | CA12 800/4885CA1 1198/4885CA2 516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.